Safeguard Scientifics

By Jonah Comstock 03:42 pm September 11, 2018
InfoBionic, a Lowell, Massachusetts-based remote patient monitoring company, has raised $50 million in a new round of funding. Eagle Investments, Excel Venture Management, Safeguard Scientifics, Zaffre Investments (a subsidiary of Blue Cross Blue Shield of Massachusetts), and Blue Cross and Blue Shield of Kansas all contributed to the round. This round brings the company's total funding up to at...
By Jonah Comstock 03:15 pm March 22, 2017
VitalTrax, a Philadelphia-based startup focused on patient engagement in clinical trials, has received a $150,000 seed investment. It is the first investment from a new $6 million digital health fund, launched this past December, led by Ben Franklin Technology Partners, Safeguard Scientifics, and Independence Health Group.  "With its strong leadership and dedication to consumerizing the...
By Jonah Comstock 03:25 pm December 8, 2016
Independence Health Group, the parent company of Independence Blue Cross, will be one of three companies to pitch in $2 million toward a new funding initiative for early stage digital health companies in Philadelphia. Investor/accelerator groups Ben Franklin Technology Partners and Safeguard Scientifics will also pitch in $2 million each, making a total of $6 million available. "While we will...
By Heather Mack 10:23 pm October 19, 2016
Madison, Wisconsin-based Propeller Health has closed a $21.5 million Series C financing round, with new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, plus existing investors Safeguard Scientifics and Social Capital. The funding will be used to further Propeller’s digitally-guided therapy platform. Propeller’s aim is to simplify management of chronic respiratory diseases like asthma...
By Heather Mack 03:27 pm July 19, 2016
As we come to the midyear point of digital health funding, two reports from Rock Health and CB Insights offer up analysis of how 2016 is coming along.   Rock Health reported just more than $2 billion in total venture funding – on track with the levels of both 2014 and 2015. While funding hasn’t continued to surge upwards as it has in the past, Rock Health analysts Mitchell Mom and Ashlee Adams...
By Aditi Pai 07:59 am August 5, 2015
Lowell, Massachusetts-based remote patient monitoring company InfoBionic has raised $8 million led by existing investor Safeguard Scientifics. Other existing investors also contributed to the round, including Excel Venture Management and Zaffre Investments, a subsidiary of Blue Cross Blue Shield of Massachusetts. When InfoBionic raised a previous funding round, in November 2014, the company...
By Aditi Pai 04:00 am April 16, 2015
Boston-based meQuilibrium, which has developed a mobile stress management program, raised $9 million in a funding round led by Safeguard Scientifics with participation from Chrysalis Ventures. “Stress is the number one threat to employee well-being today -- contributing to chronic health conditions, absence, lost productivity, and unhealthy lifestyle behaviors,” meQuilibrium CEO Jan Bruce said in...
By Aditi Pai 09:04 am November 24, 2014
Lowell, Massachusetts-based remote patient monitoring company InfoBionic raised $17 million in a round led by Safeguard Scientifics, which now owns 20 percent of the company. Other investors that participated in the round include Excel Venture Management, Zaffre Investments and existing investors Mass Medical Angels (MA2), Broadview Ventures, TiE, Beta Fund, Boardwalk, Launchpad Venture Group,...
By Brian Dolan 06:13 am September 4, 2014
Madison, Wisconsin-based Propeller Health, formerly known as Asthmapolis, has raised $14.5 million in a round of funding led by Safeguard Scientifics with participation from return backer The Social+Capital Partnership. Propeller has also hired Practice Fusion's Chris Hogg as its first COO, and he'll head up the company's new San Francisco office. The smart inhaler company's devices and companion...
By Aditi Pai 05:57 am February 6, 2014
Molecular diagnostic company Myriad Genetics has acquired Crescendo Biosciences for $270 million, in cash, which included repayment of a $25 million loan that Myriad made to Crescendo in 2011. Investor Safeguard Scientifics has invested $11 million Crescendo Biosciences, giving it a 13 percent stake, and expect to earn $40 million as part of the deal. Following the acquisition, William Hagstrom,...